Medical AI Just Hit 90% Accuracy. But Why Can't Hospitals Trust It?
A new Nature Medicine study shows on-premise medical AI agents can diagnose at near-cloud accuracy. The bigger story is why the field still can't agree on how to know when to trust them.
Editor's picks
See all
Why Simple Maths Keeps Beating Billion-Parameter AI Cell Models
A run of careful benchmarks shows that huge single-cell foundation models often fail to beat plain linear methods. Here is what the reckoning means for AI in biology.
Pentagon Bets $47M That AI Can Out-Evolve the Next Bioweapon
The World Just Built an AI Factory for the Next Pandemic
AI Co-Scientists Are Here, and Nature Just Put Them to the Test
This Open-Source AI Just Beat 23 of 26 Radiologists
AI
See all
Virology
See all
Recent posts
See all
The AI Biotech With 37,000 Virtual Employees Just Published in Science
Stanford's 37,000-agent Virtual Biotech mined 55,984 clinical trials and independently designed a lung cancer drug strategy Merck was already pursuing.
Big Pharma's AI Arms Race: Why Novo Nordisk Just Bet on Claude
Novo Nordisk just added Anthropic's Claude Science to an AI drug discovery stack that already includes OpenAI. Here's what the deal reveals about AI in healthcare.
AI Says It Can Beat the WHO at Picking Flu Vaccines. Can It?
A new protein-language-model study claims to out-predict the WHO's flu vaccine picks, reviving a live dispute over whether AI truly beats expert judgement here.
Tiny AI Models Just Outsmarted the Frontier Giants on Ageing Science
A new Cell study pits 18 leading AI systems against ageing biology data. Small, specialised models beat every frontier system, and the whole toolkit is free to use.
Delphy: Bayesian Phylogenetics at Outbreak Speed
Delphy reformulates Bayesian phylogenetics around explicit mutations and runs in a browser, cutting an H5N1 outbreak analysis from over 21 days to 42 minutes.
Pharma's Locked Structures Just Trained an AI
Five pharmaceutical companies fine-tuned OpenFold3 on 20,167 private protein–ligand structures without pooling the data. Protein–ligand accuracy jumped from 35.6% to 52.1%. Here is what that means for drug discovery, antiviral design and pandemic preparedness.
Biology
See all
Evolution as Training Data: How Biohub's Open Protein World Model Is Rewiring Drug Discovery
Biohub's open-source ESM models learned the rules of protein biology from evolution alone — and designed working drug binders in days. Here's what the release means, and where it falls short.
